HBK INVESTMENTS L P - BIOHAVEN PHARMACTL HLDG CO L ownership

Back to all holdings Add to watchlist

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 330 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 1.1%.

Links
Filings
EDGAR links
External links
Quarter-by-quarter ownership
HBK INVESTMENTS L P ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$536,653,500
+346.4%
3,550,000
+330.3%
3.87%
+467.2%
Q2 2022$120,210,750
+3331.7%
825,000
+931.2%
0.68%
+2100.0%
Q2 2019$3,503,000–80,000–0.03%–
 Download
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q2 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 450,422$6,251,85714.11%
Liontrust Investment Partners LLP 134,659$7,478,9610.13%
Birchview Capital, LP 7,365$1020.07%
FNY Investment Advisers, LLC 250$30.00%
FNY Investment Advisers, LLC 18$00.00%
FNY Investment Advisers, LLC 56$00.00%
McElhenny Sheffield Capital Management, LLC 31$4300.00%
Blue Trust, Inc. 65$100.00%
IFP Advisors, Inc 1$10.00%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders